NCT07415031 2026-02-17
A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib Studies
Mirati Therapeutics Inc.
Phase 2 Not yet recruiting
Mirati Therapeutics Inc.
Shanghai Zhongshan Hospital
Fujian Cancer Hospital
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Liaoning Cancer Hospital & Institute